|
セキグチ ハルキ
SEKIGUCHI Haruki
関口 治樹 所属 医学部 医学科(東京女子医科大学病院) 職種 准教授 |
|
| 言語種別 | 英語 |
| 発表タイトル | Impact of Baseline Low-Density Lipoprotein cholesterole Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial |
| 会議名 | American Heart Association (AHA) Scientific Sessions 2018 |
| 主催者 | American Heart Association (AHA) |
| 学会区分 | 国際学会及び海外の学会 |
| 発表形式 | ポスター掲示 |
| 講演区分 | 一般 |
| 発表者・共同発表者 | ◎WATANABE Erisa, YAMAGUCHI Junichi, SEKIGUCHI Haruki, IM Jihaeng, SUZUKI Keisuke, OGISO Masataka, ARASHI Hiroyuki, OGAWA Hiroshi, HAGIWARA Nobuhisa, and HIJ-PROPER Investigators |
| 発表年月日 | 2018/11/10 |
| 開催地 (都市, 国名) |
Chicago, USA |
| 概要 | *Session Title: Lipids, Lipoproteins and Risk of Coronary Artery Disease
Conclusions: In statin naïve ACS patients showing LDL-C value less than 140mg/dl on admission, intensive lipid lowering therapy, adding ezetimibe to pitavastatin, did not improve clinical outcome in comparison with pitavastatin monotherapy, regardless significant lower LDL-C value after 3-year. Another approach, other than ezetimibe, for lipid lowering should be warranted in this population. |